How to Dose Quercetin Correctly: What the Research Recommends

Leila WehrhahnUpdated:

Key points at a glance:

Typical quercetin intakes in studies range from 500 to 1000 mg per day over 8 to 12 weeks. Enhanced formulations are designed to provide similar exposure with lower milligram amounts. During periods when allergies are more common, data on EMIQ (an enzymatically modified form of quercetin) indicate study intakes of around 100 to 200 mg per day. In the context of exercise and recovery, around 1000 mg is often used around periods of physical exertion in research settings. Observed effects on blood pressure in studies tend to be small. Quercetin is usually taken with a meal. Potential interactions have been discussed in relation to blood-thinning medication, blood pressure medication, thyroid function and iron status. There are currently no authorised EU health claims for quercetin.

Important notice: This article is for general information only and is not a substitute for medical advice, diagnosis or treatment. Speak to your doctor or pharmacist before taking food supplements – especially if you have existing health conditions, are pregnant/breastfeeding, or are taking medication.

Quercetin has become a popular supplement among people interested in heart health, inflammation and healthy ageing. Dosing, however, is not straightforward. The amount your body actually absorbs varies a lot between different formulations, and online recommendations range from very low to very high.

This evidence‑informed guide summarises what human studies suggest about quercetin dosing – with a focus on:

  • Cardiovascular and metabolic health
  • Seasonal allergies and histamine symptoms
  • Exercise recovery
  • The sensitive topic of senolytics and healthy ageing

It is aimed at health‑conscious UK adults who want practical, responsible information rather than hype.

What is quercetin and how does it work?

Quercetin is a flavonol – a type of polyphenol – naturally present in foods such as onions, apples and capers. In laboratory and animal research, quercetin has been linked to:

  • Antioxidant and anti‑inflammatory actions
  • Stabilising mast cells (involved in allergy responses)
  • Influencing Nrf2 and AMPK signalling pathways (linked with cellular stress responses and metabolism)
  • Potential senolytic effects when combined with the prescription drug dasatinib

At present, no health claims for quercetin are authorised in the EU or UK. That means it cannot legally be marketed as treating or preventing any disease. EFSA assessment on quercetin health claims.

🔍 To sum up

Quercetin is a naturally occurring plant compound found in foods such as onions and apples. It may influence various biological processes, but there are currently no authorised EU or UK claims for specific health benefits.

Where does human research on quercetin show promising signals?

1) Cardiometabolic health and blood pressure

  • Blood pressure: Several meta-analyses of randomised controlled trials report small but statistically significant reductions in systolic and diastolic blood pressure – usually around 2–4 mmHg – mainly at doses of ≥500 mg/day for at least 8 weeks. AHA meta-analysis.
  • Fasting glucose: A 2024 meta-analysis in people with metabolic syndrome or type 2 diabetes found small reductions in fasting blood glucose, although study results were quite varied. 2024 meta-analysis (Journal of Functional Foods).
🔍 To sum up

In human studies, quercetin shows modest positive effects on blood pressure and fasting blood sugar. These changes are small and should be seen as a possible complement to – not a replacement for – healthy lifestyle measures and prescribed treatment.

2) Seasonal allergies and histamine‑related symptoms

Quercetin has been studied in modified forms for seasonal allergy symptoms:

  • In people with seasonal allergic rhinoconjunctivitis, EMIQ (enzymatically modified isoquercitrin – a highly absorbable form of quercetin) improved mainly eye symptoms (itching, watering) in small randomised trials.
  • Effects on nasal symptoms were more inconsistent.
  • Typical research dose: 100 mg/day of EMIQ. EMIQ RCT (Int Arch Allergy Immunol).

3) Sport, exercise recovery and performance

For active adults and athletes:

  • Performance: Meta-analyses suggest, on average, trivial to small performance benefits only.
  • Recovery: There is clearer evidence for reduced markers of muscle damage and soreness at around 1000 mg/day taken for at least 7 days around intense exercise. Performance meta-analysis, Recovery meta-analysis 2023.

4) Healthy ageing and senolytics (D+Q)

Quercetin is sometimes discussed in the context of senolytics – interventions that may help clear senescent (non‑dividing) cells. Current human data are very early and involve a prescription medicine:

  • Small pilot studies using dasatinib plus quercetin (D+Q) in conditions such as idiopathic pulmonary fibrosis (IPF) and diabetic kidney disease reported improvements in physical function and reductions in markers linked with senescent cells.
  • Protocols used intermittent, short “hit‑and‑run” dosing, under specialist medical supervision. D+Q human studies.

This approach is experimental and not appropriate for self‑experimentation.

Further reading: Quercetin, resveratrol and fisetin compared.

Quercetin bioavailability: why form and food make a big difference

One of the key issues with quercetin is bioavailability – how much actually reaches your bloodstream. Different formulations can produce very different blood levels from the same milligram dose.

  • Standard quercetin (aglycone/dihydrate): The reference form used in many studies. Absorption is relatively low and varies noticeably between individuals.
  • Phytosome (quercetin–lecithin complex): In one pharmacokinetic study, this form produced up to about 20‑fold higher plasma levels compared with unformulated quercetin. Phytosome PK.
  • EMIQ (enzymatically modified isoquercitrin): Shows markedly higher bioavailability. Human studies report higher metabolite levels and acute improvements in endothelial (blood vessel) function at relatively low mg/kg doses. EMIQ & endothelial function.
  • Other enhanced systems: These include self‑emulsifying galactomannans and γ‑cyclodextrin complexes. A recent review reports approximate exposure increases of up to ~62‑fold (self‑emulsifying galactomannans), ~20‑fold (phytosome) and ~10.8‑fold (γ‑cyclodextrin). Systematic review 2025.
  • Effect of food: Taking quercetin with food – especially containing some fat and fibre – may roughly double absorption, compared with taking it on an empty stomach. Review 2025.
🔍 To sum up

Different quercetin formulations can produce very different blood levels. Enhanced forms (such as phytosome and EMIQ) often deliver similar or greater exposure with much lower milligram doses. Quercetin is generally better absorbed when taken with meals.

Practical quercetin dosing guide for adults

General note: Quercetin is a food supplement, not a medicine. It is not intended to diagnose, treat, cure or prevent any disease. Always discuss use with a healthcare professional if you:

  • Take prescription medicines (especially for blood pressure, clotting or thyroid function)
  • Are pregnant or breastfeeding
  • Have thyroid problems or low iron stores

A) Cardiometabolic support and blood pressure

  • Standard quercetin: 500 mg/day is a common starting dose. Some studies used 500 mg twice daily (1000 mg/day) for stronger cardiometabolic effects. Typical study duration: 8–12 weeks. Blood pressure meta-analysis.
  • Enhanced forms (phytosome, EMIQ, etc.): Follow the manufacturer’s guidance on “aglycone equivalent” dosing. Because absorption is higher, much lower milligram amounts are often used to approximate the exposure from 500–1000 mg/day of standard quercetin. Phytosome PK.

B) Seasonal allergies and histamine load

  • EMIQ (preferred where available): 100–200 mg/day during the allergy season, ideally starting 2–4 weeks before your typical symptom onset. Evidence is strongest for itchy, watery eyes; nasal symptoms (sneezing, congestion) show more variable responses. EMIQ RCT.
  • Standard quercetin (if EMIQ is not available): In practice, many people use 250–500 mg twice daily during high‑pollen periods. The evidence base for this form is weaker than for EMIQ or certain combination products.

C) Sports recovery and heavy training blocks

  • Recovery focus: 1000 mg/day (for example 2 × 500 mg) of standard quercetin, taken for at least 7 days around intensive training or events. Studies mainly report reduced soreness and lower muscle damage markers; performance gains are usually small. Meta-analysis 2023.

D) Blood pressure in pre‑/mild hypertension

  • 500–1000 mg/day of standard quercetin for at least 8 weeks has been associated with small average reductions in blood pressure in studies. It should be considered only as an add‑on to lifestyle measures (diet, weight management, physical activity) and prescribed treatment – never a substitute.
  • Use a reliable home blood pressure monitor and track readings regularly. AHA meta-analysis.

E) Senolytic protocols (D+Q) – medical supervision only

Important: Senolytic protocols studied in humans have used intermittent “hit‑and‑run” dosing with dasatinib 100 mg plus quercetin 1000–1250 mg daily for 2–3 consecutive days (once, or once weekly for 3 weeks). Dasatinib is a prescription cancer medicine with significant potential risks. These protocols are experimental, require specialist supervision and are not suitable for self‑use. D+Q studies.

Timing, cycles and practical use

  • Take quercetin with meals that contain some fat; this generally improves tolerability and absorption.
  • If you are prone to digestive upset, split the dose (for example morning and evening).
  • For longer‑term use, some practitioners use 8–12 weeks “on”, followed by 2–4 weeks “off” to reassess. This is a pragmatic approach; there is limited direct evidence on cycling itself.

Study‑oriented quercetin dosing ranges

Goal Form Daily dose Duration Evidence level
Cardiometabolic (incl. BP) Standard 500–1000 mg 8–12 weeks Moderate (meta-analyses)
Allergy season (eye symptoms) EMIQ 100–200 mg 8 weeks in season Low–moderate (small RCTs)
Sports recovery Standard 1000 mg ≥7 days around exertion Moderate (meta-analysis)
Senolytic (D+Q) Rx combination Q 1000–1250 mg + dasatinib 100 mg 2–3 days, intermittent Pilot data (medical setting only)

Comparing quercetin formulations: what lower milligram doses can mean

  • Standard quercetin (aglycone/dihydrate): Baseline reference; most traditional dosing guidance (e.g. 500–1000 mg/day) refers to this form.
  • Phytosome (lecithin complex): Around up to 20‑fold higher exposure in one study, so supplements commonly use much lower milligram amounts for a similar systemic effect. Phytosome PK data.
  • EMIQ/isoquercitrin: Significantly increased bioavailability; human data show vascular effects at relatively low doses compared with standard quercetin. EMIQ human study.
  • Other enhancers: γ‑cyclodextrin complexes (~10.8× exposure) and self‑emulsifying galactomannans (~62×) have been reported. Review 2025.

Safety, interactions and who should be cautious

  • General tolerability: Trials using 500–1000 mg/day of standard quercetin for up to 12 weeks have rarely reported serious adverse events. Mild headaches and gastrointestinal symptoms (such as nausea or stomach discomfort) are the most commonly reported issues. Safety RCT, PK variability.
  • Potential interactions – speak to your pharmacist or doctor:
    • Anticoagulants (e.g. warfarin): Case reports describe increased INR and bleeding risk when quercetin is combined with warfarin. Use only with careful medical monitoring, or avoid entirely. Warfarin case report.
    • Antihypertensives: Because quercetin may slightly lower blood pressure, there is a potential for additive effects with blood pressure medication. Monitor blood pressure at home if combining. Blood pressure meta-analysis.
    • Drug transporters/enzymes: Quercetin can affect P‑gp, CYP and OATP transporters. In human studies, it has increased blood levels of the antihistamine fexofenadine and moderately increased exposure to the statin pravastatin (OATP1B1). Fexofenadine study, Pravastatin interaction.
  • Thyroid considerations: Preclinical research suggests quercetin may downregulate thyroid‑specific genes and influence deiodinase enzymes. If you have a thyroid condition or take levothyroxine, discuss quercetin with your doctor; monitoring TSH and T4 may be sensible during longer‑term use. Food Chem Toxicol 2014.
  • Iron status: Polyphenols such as quercetin can reduce absorption of non‑haem iron from food and supplements. If you have low ferritin or take iron tablets, consider leaving at least 2–3 hours between iron and quercetin. European Journal of Nutrition 2019.
  • Pregnancy and breastfeeding: Robust human data are lacking. Use only on medical advice and generally with caution.
  • Kidney disease and polypharmacy: If you have reduced kidney function or are on several prescription medicines, seek advice from your GP or specialist before starting quercetin.
🔍 To sum up

Short‑term use of 500–1000 mg/day of standard quercetin appears generally well tolerated in studies. However, safety is highly individual. Medication use, thyroid health and iron status are important when deciding whether quercetin is appropriate for you.

Quercetin from food: how much can you realistically get from your diet?

Some everyday foods contain useful amounts of quercetin:

  • Capers (raw/drained): Roughly 170–230 mg per 100 g
  • Red and yellow onions: Several tens of milligrams per 100 g, particularly in the outer layers
  • Herbs such as lovage and dill: Relatively rich sources
  • Apples and berries: Lower amounts per typical serving

Actual values vary widely depending on variety, growing conditions and processing. USDA flavonoid database (Release 3.3), Review article with USDA table.

For most people eating a typical European‑style diet, daily quercetin intake from food is likely in the low tens of milligrams at best. Supplements are usually required to reach the amounts used in intervention studies (e.g. 500–1000 mg/day). USDA flavonoid data.

Choosing a quercetin supplement: formulation and quality

  • What to look for:
    • Clear labelling of the form (e.g. quercetin dihydrate, quercetin phytosome, EMIQ)
    • Stated milligrams per capsule/tablet and, for enhanced forms, “aglycone equivalent” where relevant
    • Evidence of batch testing or third‑party quality assurance
  • What to avoid:
    • Proprietary blends that do not disclose exact milligram amounts
    • Products claiming to treat, cure or prevent specific diseases
  • Storage and shelf life:
    • Store away from heat, light and moisture
    • Check best‑before dates
    • Consider established brands or pharmacies

You can find a curated overview of selected products for healthy ageing in our longevity collection.

Should you consider quercetin? A simple decision checklist

  1. Clarify your main goal:
    • Support for cardiometabolic health or blood pressure?
    • Seasonal allergy support (especially eye symptoms)?
    • Faster recovery from demanding training sessions?
  2. Review your medication list:
    • Do you take anticoagulants (e.g. warfarin), blood pressure drugs, antihistamines (e.g. fexofenadine), statins or other long‑term prescription medicines?
    • If yes, speak to your doctor or pharmacist before starting quercetin.
  3. Consider thyroid and iron status:
    • History of thyroid disease or on levothyroxine?
    • Low ferritin or a tendency to iron‑deficiency?
    • In these cases, clarify with your clinician first.
  4. Choose a formulation:
    • Standard quercetin for straightforward, study‑aligned dosing
    • Enhanced forms (phytosome, EMIQ) if you prefer lower milligram doses and potentially higher absorption
  5. Plan a trial period:
    • Typically 8–12 weeks, taken with meals
    • Track relevant metrics (blood pressure, allergy symptoms, recovery) and review your experience afterwards.

How to use quercetin more safely: step‑by‑step

  1. Set a clear objective: For example, “I want to see whether quercetin modestly supports my blood pressure alongside my current plan”, or “I want to see whether my hay fever eye symptoms improve”.
  2. Select the form and starting dose:
    • Use the dosing guide above as a reference.
    • When in doubt, start at the lower end of the suggested range.
  3. Baseline measurements and tracking:
    • Blood pressure: Record 1–2 weeks of readings before starting. Then take 2–3 readings per day in the first 2 weeks on quercetin.
    • Allergy: Use a brief symptom diary (eyes and nose) and note any antihistamines used.
    • Recovery: Rate muscle soreness daily on a 0–10 scale; more advanced users may track creatine kinase (CK) with their clinician.
  4. Review after 8–12 weeks:
    • Compare your logs (before vs during supplementation).
    • Decide whether to continue, adjust the dose, switch formulation or take a break.
    • If you have relevant risk factors, discuss whether checking ferritin and thyroid markers (TSH/T4) is appropriate.
  5. Coordinate with healthcare professionals:
    • Always involve your GP or pharmacist if you take prescription medicines, have thyroid or iron issues, or are considering any senolytic‑type approach.
Practical tip: Onion‑rich dishes with added capers – for example, Mediterranean‑style pans or salads – are an easy way to increase natural quercetin intake. Try to use more of the outer onion layers, and be aware that long cooking times can reduce polyphenol content.

If you are considering quercetin, discuss it with your GP or pharmacist – especially if you use blood pressure medication, blood thinners, thyroid medication or iron supplements. Keeping a simple 8–12 week log of blood pressure readings, allergy symptoms or recovery can help you assess your own response in a structured, objective way.

Related posts

Frequently Asked Questions

Can I combine quercetin with vitamin C or bromelain?

Yes, that is common. Robust evidence for a strong “synergy” is limited; stay within the dosage ranges mentioned above.

Take it in the morning or evening?

With meals (a little fat improves absorption). If you have a sensitive stomach, split the daily dose into 2 portions.

How quickly will I notice effects?

Allergies: days to a few weeks. Blood pressure: more likely ≥8 weeks. Recovery: often within 1–2 weeks of continuous use.

Is year-round daily use sensible?

Only if there is a clear benefit and no safety signals. Otherwise, use in cycles (e.g. 8–12 weeks on, 2–4 weeks off) and reassess regularly.

How we reviewed this article:

Sources

Our content is based on peer-reviewed studies, academic research institutions, and medical journals. We only use high-quality, credible sources to ensure the accuracy and integrity of our content.

  • [1] Serban MC et al. Effects of Quercetin on Blood Pressure: A Systematic Review and Meta‑Analysis of Randomized Controlled Trials , Volume 5 , Issue 7 , 2016-07-12 , Pages e002713
    pmc.ncbi.nlm.nih.gov/articles/PMC5015358/
  • [2] Noshadi N et al. The effect of quercetin supplementation on the components of metabolic syndrome in adults: A systematic review and dose–response meta‑analysis of randomized controlled trials , Volume 116 , Issue , 2024-05-01 , Pages 106175
    www.sciencedirect.com/science/article/pii/S1756464624001774
  • [3] Liu L, Barber E, Kellow NJ, Williamson G Improving quercetin bioavailability: A systematic review and meta‑analysis of human intervention studies , Volume 477 , Issue , 2025-06-15 , Pages 143630
    pubmed.ncbi.nlm.nih.gov/40037045/
  • [4] Riva A et al. Improved Oral Absorption of Quercetin from Quercetin Phytosome®, a New Delivery System Based on Food Grade Lecithin , Volume 44 , Issue 2 , 2019-04-01 , Pages 169-177
    pubmed.ncbi.nlm.nih.gov/30328058/
  • [5] Bondonno NP et al. Enzymatically modified isoquercitrin improves endothelial function in volunteers at risk of cardiovascular disease , Volume 123 , Issue 2 , 2020-01-28 , Pages 182-189
    pubmed.ncbi.nlm.nih.gov/31870463/
  • [6] Kawai M et al. Effect of enzymatically modified isoquercitrin on symptoms of Japanese cedar pollinosis: a randomized double‑blind placebo‑controlled trial , Volume 149 , Issue 4 , 2009-03-17 , Pages 359-368
    pubmed.ncbi.nlm.nih.gov/19295240/
  • [7] Rojano‑Ortega D et al. Quercetin supplementation promotes recovery after exercise‑induced muscle damage: a systematic review and meta‑analysis of randomized controlled trials , Volume 40 , Issue 3 , 2023-07-01 , Pages 813-825
    pubmed.ncbi.nlm.nih.gov/37398956/
  • [8] Kressler J, Millard‑Stafford M, Warren GL Quercetin and endurance exercise capacity: a systematic review and meta‑analysis , Volume 43 , Issue 12 , 2011-12-01 , Pages 2396-2404
    pubmed.ncbi.nlm.nih.gov/21606866/
  • [9] Kim KA et al. Short‑term effect of quercetin on the pharmacokinetics of fexofenadine, a substrate of P‑glycoprotein, in healthy volunteers , Volume 64 , Issue 2 , 2009-02-01 , Pages 124-130
    pubmed.ncbi.nlm.nih.gov/19221726/
  • [10] Patel R, Stine A, Zitko K Enhanced Anticoagulant Effect of Warfarin When Co‑administered With Quercetin (case report) , Volume 38 , Issue 6 , 2022-09-24 , Pages 374-375
    pmc.ncbi.nlm.nih.gov/articles/PMC9608098/
  • [11] Giuliani C et al. The flavonoid quercetin inhibits thyroid‑restricted genes expression and thyroid function , Volume 66 , Issue , 2014-04-01 , Pages 23-29
    pubmed.ncbi.nlm.nih.gov/24447974/
  • [12] Bao W et al. Quercetin inhibits intestinal non‑haem iron absorption by regulating iron metabolism genes in the tissues , Volume 58 , Issue , 2019-03-28 , Pages 743–753
    link.springer.com/article/10.1007/s00394-018-1680-7
  • [13] Hickson LJ et al. Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease , Volume 47 , Issue , 2019-09-01 , Pages 446-456
    pubmed.ncbi.nlm.nih.gov/31542391/
  • [14] EFSA NDA Panel Scientific Opinion on the substantiation of health claims related to quercetin … pursuant to Article 13(1) of Regulation (EC) No 1924/2006 , Volume 9 , Issue 4 , 2011-04-08 , Pages 2067
    efsa.onlinelibrary.wiley.com/doi/abs/10.2903/j.efsa.2011....
  • [15] USDA ARS (Bhagwat S, Haytowitz DB) USDA Database for the Flavonoid Content of Selected Foods, Release 3.3 (March 2018) , Volume , Issue , 2018-03-01 , Pages
    agdatacommons.nal.usda.gov/articles/dataset/USDA_Database...
  • [16] He J et al. Inhibition of the organic anion‑transporting polypeptide 1B1 by quercetin: an in vitro and in vivo assessment , Volume 73 , Issue 2 , 2011-12-01 , Pages 294–306
    pmc.ncbi.nlm.nih.gov/articles/PMC3403202/
  • [17] Nieman DC et al. Quercetin supplementation and upper respiratory tract infection: A randomized community clinical trial , Volume 62 , Issue 2 , 2010-08-01 , Pages 113–122
    pubmed.ncbi.nlm.nih.gov/20478383/
Show More